D3

Artefact, architecture and time; Editorial in QSHC

Digitalisation of medicines: artefact, architecture and time

doi:10.1136/bmjqs-2017-006661

In an editorial in QSHC Tony Cornford and Valentina Lichtner look at current digital initiative around medicines, in particular electronic prescribing. They offer a new vision for the future based on  new  platform architectures in support of a more digitally active kind of medicines. In particular, they suggest that safety in the systems […]

Warfarin History Timeline

One of the presentations on the workshop Digital Transformations in Healthcare held recently at LSE was on the material and digital transformations of warfarin. The poster prepared for this event is too large to upload on this site but is available here:

http://ejdickson6.wixsite.com/thewarfarinproject/warfarin-history

May 15th, 2017|D3, Workshop|0 Comments|

New video – Warfarin: an informed and digital drug

Recently, we filmed an interview with Nick Barber, Pharmacist and Professor Emeritus at University College London. Our interviewer is Ralph Hibberd, one of our D3 team members. The interview is presented in three parts: Warfarin and the Pharmaceutical Gaze, Warfarin and the New Medicines Service and Warfarin as a Digital Drug.

You will find all our videos under the menu […]

March 20th, 2017|D3|0 Comments|

Video: Warfarin and the New Medicines Service

Recently, we filmed an interview with Nick Barber, Pharmacist and Professor Emeritus at University College London. Our interviewer is Ralph Hibberd, one of our D3 team members. The interview is presented in three parts: Warfarin and the Pharmaceutical Gaze, Warfarin and the New Medicines Service and Warfarin as a Digital Drug.

You will find all our videos under the menu […]

March 2nd, 2017|D3|0 Comments|

Brexit and the Falsified Medicines Directive

In order to help patients avoid being exposed to falsified medicines, the European Commission developed a series of measures to support patients in identifying licenced suppliers of pharmaceutical medicines, and suppliers to identify whether an end-user pack of medicines was genuine. The measures outlined in the Falsified Medicines Directive (2011/62/EU) have been applied across the European Union (EU), with […]

  • Permalink Gallery

    Hub and Spoke Dispensing: Privacy and Sociotechnical Rigidity

Hub and Spoke Dispensing: Privacy and Sociotechnical Rigidity

In a previous post, we noted how a hub and spoke model for community pharmacy had been promoted on the basis of a limited safety case. The hub and spoke model that was described was one in which items would be assembled at a hub site that would serve a number of dispensing sites, such as community pharmacies. Although […]

Survey Results

Thank you to all who took the time to fill out the survey.

The results are in and, combined with the WordPress stats, there are some interesting things to note:

People who responded included: academic; NHS clinicians; patients/carers; third sector; business/industry and ‘other’ (nurse in private health care).
Some were new visitors and some more frequent, but all found the site ‘easy’ […]

May 23rd, 2016|D3|0 Comments|

Serialisation of Individual Pills to Defeat Counterfeiters

At present, proposals to prevent falsified medicines entering supply networks has focussed on increasingly sophisticated packaging including tamper evident seals, electronic recording of unique serialised package identities, or the use of assays in the sampling of purported therapeutic drugs. An alternative solution, being developed by Dr Phil Harrison and colleagues, is to use sets of four and six machine-actuated pins to add micro-indentation codes on […]

D3 Research presents a poster at the LSE Research Festival

Delivering Digital Drugs was presented at the LSE Research Festival Exhibition 2015, on Thursday 21 May 2015, 5.30pm-8.30pm, with a poster.

May 29th, 2015|D3|0 Comments|

Researching Digitalization – D3 Workshop 19 May 2015 at LSE

A workshop on Researching Digitalization was held at the LSE on 19th of May 2015. Organised by the D3 project, this is the first of a series of workshops planned in the context of researching Digital Drugs.

Here the workshop call for contributions, a summary of the event and notes of the mapping exercise.

 

May 20th, 2015|D3, Research|0 Comments|